Drug Research
Berkshire Sterile to offer formulation, lyophilization, and method development services
Berkshire Sterile Manufacturing (BSM), a sterile filling contract manufacturer located in Lee, MA, has recently added formulation, lyophilization, and method development capabilities to complement their clients’ drug productions.
BSM will now offer first-in-human formulation development, supply material for preclinical studies,...
News
AGC Biologics Supports BioNTech Omicron-based Vaccine Candidate with pDNA Starting Material
AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced an expanded partnership to supply more plasmid DNA (pDNA) starting material for the Pfizer-BioNTech COVID-19 vaccine at the company’s Heidelberg facility.
According to a recent news release...
News
mdgroup Newly Appointed Medical Director Dr Arthur Lazarus Addresses Remote Patient Healthcare Selection at SCOPE 2022
mdgroup, the leading global provider of personalised clinical study services, has appointed Dr Arthur Lazarus as Medical Director.
Dr Lazarus will also be speaking at SCOPE 2022 on Thursday 10th February,11.30am ET, discussing how proper selection of healthcare providers for...
News
One Vaccine For All Corona Variants Claim Indian Scientists
Scientists in India have claimed to have designed a vaccine, or rather a universal vaccine that can be used effectively against all the coronavirus variants that have been triggered by the once in a century pandemic that hit the...
News
Drone Delivery Already Becoming A Pharmaceutical Reality
The last couple of years have been stressful for any industry you talk about. That said, there is one sector which has proven to be starkly different, and that’s pharmaceuticals. The Indian spectrum in any industry sphere is worth...
News
Endeavor BioMedicines Closes $101M Series B Financing to Advance Clinical-Stage Precision Medicine Pipeline
Endeavor BioMedicines, a clinical-stage biotechnology company targeting the core drivers of terminal diseases including oncology and fibrosis, announced the completion of a $101 million Series B financing, led by Ally Bridge Group and Avidity Partners. New investors participating in...
News
Sartorius completes acquisition of Novasep’s chromatography division
The life science group Sartorius announced today that, through its subgroup Sartorius Stedim Biotech, it closed the acquisition of the Novasep chromatography division as of February 7, 2022, following approval by the U.S. Federal Trade Commission. The transaction had...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















